Table 1 of
Pelikan, Mol Vis 2013; 19:1453-1470. Table 1 of
Pelikan, Mol Vis 2013; 19:1453-1470.
Table 1. Characteristics of the patients
| Patients (n=32) | Control subjects n=10 | |||
| SICR (n=11) | SLCR (n=13) | SDYCR (n=8) | ||
| Age (years) | 25±6 | 32±11 | 27±4 | 30±7 |
| Sex (M/F) | 5/6 | 7/6 | 3/5 | 5/5 |
| Disease history (years) | 3.1±1.2 | 3.6±0.9 | 4.7±1.6 | 0 |
| Blood leukocyte count (x 109 /l)* | 8.1±0.9 | 8.7±1.2 | 7.5±0.8 | 7.3±0.6 |
| Blood eosinophil count (x 106 /l) ** | 305±15 | 281±20 | 293±25 | 266±47 |
| Increased total IgE in the serum *** | 0 | 0 | 0 | 0 |
| Positive specific IgE in the serum**** | 3 | 2 | 1 | 2 |
| Positive skin response ● | ||||
| - immediate type | 6 | 4 | 0 | 4 |
| - late type | 5 | 9 | 2 | 5 |
| - delayed type | 0 | 0 | 6 | 1 |
| Nasal histamine threshold ∆ | ||||
| - decreased | 7 | 5 | 1 | 5 |
| - normal | 4 | 8 | 7 | 5 |
| Nasal provocation tests ▲ | ||||
| - positive | 11 | 13 | 8 | 10 |
| - negative | 10 | 14 | 5 | 7 |
| Factors in tears | ||||
| Histamine ng/ml | <1.0 | <1.0 | <1.0 | <1.0 |
| Tryptase µg/l | <1.0 | 1.1±0.1 | <1.0 | <1.0 |
| ECP µg/l | 2.4±0.2 | 2.2±0.2 | <2.0 | <2.0 |
| EDN ng/ml | <0.64 | <0.64 | <0.64 | <0.64 |
| LTB4 pg/ml | <4.8 | <4.8 | 5.2±0.3 | <4.8 |
| LTC4 pg/ml | 2.3±0.2 | 2.4±0.3 | <2.1 | <2.1 |
| LTE4 pg/ml | <3.7 | <3.7 | <3.7 | <3.7 |
| MPO ng/ml | <25.0 | <25.0 | <25.0 | <25.0 |
| IFN-γ pg/ml | <1.0 | <1.0 | 1.4±0.2 | <1.0 |
| IL-2 pg/ml | <3.0 | <3.0 | <3.0 | <3.0 |
| IL-4 pg/ml | 1.0±0.3 | 0.8±0.1 | <0.7 | <0.7 |
| IL-5 pg/ml | <0.32 | 3.4±0.2 | <0.32 | <0.32 |